Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Stephen Liggett, Douglas Kell, Robert Lipshutz

Premium

The University of South Florida has named Stephen Liggett its new vice dean for personalized medicine and genomics. Additionally, Liggett will be the associate VP for personalized medicine at the USF Morsani College of Medicine and be the director of the university's Personalized Medicine Institute.

Liggett comes to USF from the University of Maryland School of Medicine, where he was associate dean for interdisciplinary research and director of the cardiopulmonary genomics program.


Douglas Kell has been reappointed as chief executive and deputy chair of the UK Biotechnology and Biological Sciences Research Council.

Kell has held the top post at BBSRC since 2008, and before that he was director of the Manchester Center for Integrative Systems Biology. He also has served as director of research at the Institute of Biological Sciences at the University of Aberystwyth, and he was a founding director of Aber Instruments.


The Institute for Systems Biology has appointed Robert Lipshutz to be chief business officer and senior VP for strategic partnerships. Lipshutz spent nearly two decades at Affymetrix in various roles focusing on business development, licensing, diagnostics, and emerging markets, and most recently as senior VP for corporate development.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.